Table 2.
Correlation between clinical parameters and HDAC2, HDAC5 and NF-κB DNA binding activity in all subjects
HDAC2 | HDAC5 | NF-κB | |
---|---|---|---|
Age | 0.04 | −0.05 | 0.01 |
Pack-year | −0.28 | −0.35 | 0.62** |
BMI (kg/m2) | 0.36 | 0.04 | −0.03 |
FEV1%predicted | 0.53** | 0.64** | −0.54** |
FEV1/FVC % | 0.55** | 0.68** | −0.53** |
RV % predicted | −0.33 | −0.33 | 0.59* |
KCO % predicted | 0.67* | 0.03 | −0.74* |
TLCO% predicted | 0.50* | 0.43 | −0.81** |
PaO2 | 0.32 | 0.39 | −0.54* |
PaCO2 | −0.16 | −0.07 | 0.30 |
MVC | 0.42* | 0.30 | −0.50* |
NF-κB | −0.59** | −0.50* | NA |
HDAC 2 protein | NA | 0.63** | −0.59** |
HDAC5 protein | 0.63** | NA | −0.50* |
HDAC1 mRNA | −0.09 | −0.02 | 0.13 |
HDAC2 mRNA | 0.14 | −0.11 | −0.27 |
HDAC5 mRNA | −0.36 | −0.44 | 0.12 |
Abbreviations: BMI body mass index, FEV 1 forced expiratory volume in 1 s, RV residual volume, KCO carbon monoxide transfer coefficient, TL CO transfer factor for carbon monoxide in the lung, MVC maximum voluntary contraction, PaO 2 partial pressure of oxygen in arterial blood, NF-κB nuclear factor-kappa B, HDAC histone deacetylase, NA not applicable
*p < 0.05; ** p < 0.01